[Metabotropic glutamate receptors as targets for new drug development] - PubMed

[Article in Russian]

• PMID: 22238988

Review

[Metabotropic glutamate receptors as targets for new drug development]

[Article in Russian]

V I Arkhipov et al. Eksp Klin Farmakol. 2011.

Abstract

The review is devoted to experimental investigations of metabotropic glutamate receptors and the properties of drugs (ligands) belonging to agonists, antagonists, and modulators of the activity of these receptors. Possibilities of the treatment of neurodegenerative disorders, cognitive disturbances in schizophrenia patients, and narcotic dependency by using drugs of this class are considered.

Similar articles

• Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.

  Ritzén A, Mathiesen JM, Thomsen C. Ritzén A, et al. Basic Clin Pharmacol Toxicol. 2005 Oct;97(4):202-13. doi: 10.1111/j.1742-7843.2005.pto_156.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16176554 Review.

• Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.

  Chaki S. Chaki S. Eur J Pharmacol. 2010 Aug 10;639(1-3):59-66. doi: 10.1016/j.ejphar.2009.12.041. Epub 2010 Apr 2. Eur J Pharmacol. 2010. PMID: 20371240 Review.

• The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801.

  Vales K, Svoboda J, Benkovicova K, Bubenikova-Valesova V, Stuchlik A. Vales K, et al. Eur J Pharmacol. 2010 Aug 10;639(1-3):91-8. doi: 10.1016/j.ejphar.2009.11.067. Epub 2010 Apr 2. Eur J Pharmacol. 2010. PMID: 20371226

• Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition.

  Marek GJ. Marek GJ. Eur J Pharmacol. 2010 Aug 10;639(1-3):81-90. doi: 10.1016/j.ejphar.2010.02.058. Epub 2010 Apr 2. Eur J Pharmacol. 2010. PMID: 20371229 Review.

• The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders.

  Bruno V, Caraci F, Copani A, Matrisciano F, Nicoletti F, Battaglia G. Bruno V, et al. Neuropharmacology. 2017 Mar 15;115:180-192. doi: 10.1016/j.neuropharm.2016.04.044. Epub 2016 Apr 30. Neuropharmacology. 2017. PMID: 27140693 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information